Evaluating the Effectiveness of Sildenafil at Improving Health Outcomes and Exercise Ability in People With Diastolic Heart Failure (The RELAX Study)

PHASE3CompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Heart Failure
Interventions
DRUG

Placebo

DRUG

Sildenafil

Trial Locations (10)

27705

Duke University Medical Center, Durham

30310

Morehouse School of Medicine, Atlanta

55415

Minnesota Heart Failure Network, Minneapolis

55905

Mayo Clinic, Rochester

77030

Baylor College of Medicine, Houston

84107

University of Utah Health Sciences Center, Murray

85054

Mayo Clinic Arizona, Phoenix

02115

Brigham and Women's Hospital, Boston

05401

University of Vermont - Fletcher Allen Health Care, Burlington

H1T - 1C8

Montreal Heart Institute, Montreal

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Pfizer

INDUSTRY

lead

Duke University

OTHER

NCT00763867 - Evaluating the Effectiveness of Sildenafil at Improving Health Outcomes and Exercise Ability in People With Diastolic Heart Failure (The RELAX Study) | Biotech Hunter | Biotech Hunter